跳至主要内容
临床试验/2024-514089-37-00
2024-514089-37-00招募中2 期

GLO-Surgery: Indocyanine Green and near infrared fLuorescence in paediatric Oncology surgery

The University Of Birmingham1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年4月1日最近更新:
干预措施

试验速览

阶段
2 期
状态
招募中
入组人数
30
试验地点
1

研究概览

简要总结

• To identify number of lymph nodes removed in patients having a nephroureterectomy for renal cancer where surgery includes the use of ICG/NIRF for lymph node harvest and compare this data to those who have had the same surgery but without the use of ICG/NIRF • To identify number of lymph nodes removed during retroperitoneal lymph node dissection (RPLND) for paratesticular rhabdomyosarcoma in patients having ICG guided nodal harvest

入排标准

年龄范围
0 years 至 65+ years(0-17 Years, 65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Undergoing surgery via open laparotomy and/or thoracotomy, minimally invasive thoracoscopic, transperitoneal or retroperitoneoscopic surgery
  • Documented negative pregnancy test for female patients of childbearing potential within 7 days of trial entry
  • Sexually active male and female patients of childbearing potential must agree to use adequate and highly effective contraception while on study up until discharge
  • Written informed consent from the patient, parent or guardian
  • Cohort 2: Any renal tumour requiring surgical resection and retroperitoneal lymph node sampling
  • Cohort 3: Histologically confirmed or presumed diagnosis of para-testicular RMS (ptRMS) with the intention to sample nodes from the ipsilateral retroperitoneum according to template dissection. Otherwise known as Retroperitoneal Lymph Node Dissection (RPLND)

排除标准

  • Allergic to ICG
  • Cohort 2: Renal tumour requiring extensive retroperitoneal or hilar dissection to access normal renal parenchyma for the ICG injection as this could damage the lymphatic vessels
  • Cohort 2: Have entered a previous randomisation within Cohort 1
  • Cohort 3: Have entered a previous randomisation within Cohort 1
  • Allergic to iodine or iodides
  • Due to receive radioactive iodine as part of treatment
  • Known Hyperthyroidism
  • eGFR <15 ml/min/1.73 m2
  • Female patients who are breastfeeding
  • Neonates requiring exchange transfusion
  • Have entered a previous randomisation within the same cohort
  • Cohort 2: Kidney wholly replaced by tumour on pre-operative imaging

研究组 & 干预措施

Verdye 5 mg/ml powder for solution for injection

Test

干预措施: Verdye 5 mg/ml powder for solution for injection (Drug)

研究者

申办方类型
Educational Institution
责任方
Principal Investigator
主要研究者

Clinical Trial Coordinator

Scientific

The University Of Birmingham

研究点 (1)

Loading locations...

相似试验